Inventor
Nils Griebenow
Inventor
Dormagen, DE
Overview
Patents· 33 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes27%
C07CAcyclic or carbocyclic compounds7%
C07KPeptides6%
PatentTitleYear
11,130,768Bicyclic pyrazole derivatives202111,077,111Use of fused heteroaromatic pyrrolidones for treatment and prevention of diseases in animals202111,001,590Pyrazolopyrimidine derivatives202110,973,923Site specific homogeneous with KSP inhibitors202110,889,573Anthelmintic quinoline-3-carboxamide derivatives202110,736,896Substituted 5-fluoro-1H-pyrazolopyridines and their use202010,604,525Pyrazolopyrimidine derivatives202010,035,818Polyethylene glycol based prodrug of adrenomedullin and use thereof201810,022,453Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)20189,993,476Substituted 5-flouro-1H-pyrazolopyridines and their use20189,771,352'Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof'20179,649,363'Polyethylene glycol based prodrug of adrenomedullin and use thereof'20179,603,936'Polyethylene glycol based prodrug of adrenomedullin and use thereof'20179,505,786'Substituted annulated triazines and use thereof'20169,315,543'Tyrosine based linkers for the releasable connection of peptides'20169,309,239'Substituted 6-fluoro-1H-pyrazolo[4,3-b]pyridines and use thereof'20169,266,885'Substituted 5-fluoro-1H-pyrazolopyridines and their use'20169,216,978'Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases'20159,150,580'Substituted imidazopyridines and the use thereof'20159,133,191'Substituted triazine derivatives and use thereof as stimulators of soluble guanylate cyclase'20159,096,592'Bicyclic aza heterocycles, and use thereof'20159,090,610'Fluoroalkyl-substituted pyrazolopyridines and use thereof'20159,090,609'Benzyl-substituted carbamates and use thereof'20159,023,849'Substituted fused imidazoles and pyrazoles and use thereof'20158,987,256'Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof'20158,921,377'Substituted 5-fluoro-1H-pyrazolopyridines and their use'20148,859,569'Substituted annellated pyrimidines and use thereof'20148,765,769'Ring-fused 4-aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases'20148,642,592'Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof'20148,420,656'Substituted 5-fluoro-1H-pyrazolopyridines and their use'20138,334,291'Aliphatically substituted pyrazolopyridines, and the use thereof'20127,776,922'Substituted [(phenylethanoyl)amino]benzamides'20107,662,956'Tetrahydrobenzo[d]azepin-2-one derivatives and the use thereof for treating cardiovascular diseases'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2021Based in Dormagen, DE· patent location history
2012–2018Patents assigned to BAYER IP GMBH (21)· patent assignee history
2012–2016Patents assigned to GRIEBENOW NILS (12)· patent assignee history
2012–2016Patents assigned to STASCH JOHANNES-PETER (12)· patent assignee history
2012–2016Patents assigned to WUNDER FRANK (12)· patent assignee history
2014–2021Patents assigned to Bayer Pharma AG (10)· patent assignee history
2021Based in Dormagen NRW, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BAYER IP GMBH | 21 | 2012–2018 |
| GRIEBENOW NILSself | 12 | 2012–2016 |
| STASCH JOHANNES-PETER | 12 | 2012–2016 |
| WUNDER FRANK | 12 | 2012–2016 |
| Bayer Pharma AG | 10 | 2014–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Dormagen, DE | 32 | 2010–2021 |
| Dormagen NRW, DE | 1 | 2021 |